FDA Inspection
Cade Medical, Inc.Cade Medical, Inc. – FDA Inspection, Sep 18, 2019
Record Details
This FDA Inspection record concerns Cade Medical, Inc., with an inspection on September 18, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · e6c4d69a-7d83-4b67-a123-bd840ddb4074
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1102523
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 1271.270(a)Records incomplete
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Cade Medical, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| August 30, 2024 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| December 29, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Cade Medical, Inc.
- FDA Inspection 1247881 - 2024-08-30
- FDA Inspection 1003866 - 2016-12-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.